The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Indirect treatment comparison of blinatumomab versus inotuzumab ozogamicin for the treatment of adult patients with relapsed or refractory acute lymphoblastic leukemia receiving zero or one prior salvage therapy.
 
Jinlin Song
Research Funding - Amgen (Inst)
 
Qiufei Ma
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Wei Gao
Research Funding - Amgen (Inst)
 
Ze Cong
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Jipan Xie
Research Funding - Amgen (Inst)
 
Zachary Franklin Zimmerman
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Laura Belton
Employment - Amgen
 
Janet Franklin
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Stephen Palmer
Consulting or Advisory Role - Amgen